The second in the three-part series that explores the multifaceted organizational and strategic decisions that companies are facing as a result of the global AIDS epidemic. Heineken considers to be one of the first companies to offer AIDS drugs (antiretroviral therapy) for employees and their families. Hans Wesseling, corporate HR manager, and his colleagues from the Faculty of Medicine to review the institutional, financial and social consequences of this decision and to make recommendations to the Council. Shows how Heineken in fighting the epidemic and considering it as part of its corporate social responsibility. "Hide
by Diane Barrett, Daniella Ballou Source: Harvard Business School 7 pages. Publication Date: January 27, 2003. Prod. #: 303064-PDF-ENG
Related Case Solutions & Analyses:
Principles of Pricing
Samsung Electronics
Denise Frazer and Paolo Canto: Case Vignette on Feedback – Paolo Cantos Perspective
Rosemary Brooks
Toyland Rubber Manufacturing: Building a New Factory in Shanghai
Royal Bank of Scotland: Masters of Integration
YM Biosciences
ECONOMICS ASSIGNMENT
Southwest airline in Nigeria
Singapore Airlines
